Search research articles
Contact Us
Filters
Showing results (1-10 of 230) with videos related to
Page
of 23
Sort By:
Rheumatology (Oxford, England)
|
December 29, 2016
Rheumatology post-Brexit
Jacob M van Laar
Therapeutic Advances in Musculoskeletal Disease
|
August 8, 2012
Stem cell therapy: resetting autoimmunity or postponing the inevitable?
Jacob M van Laar
Nature Clinical Practice. Rheumatology
|
August 30, 2007
Do high levels of IgA rheumatoid factor indicate a poor response to treatment with TNF inhibitors in patients with RA?
Jacob M van Laar
Nature Clinical Practice. Rheumatology
|
November 30, 2006
Antibodies against citrullinated proteins: which test is best?
Jacob M van Laar
Arthritis Research & Therapy
|
May 6, 2010
B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
Jacob M van Laar
Current Opinion in Rheumatology
|
September 20, 2013
Stem cell transplantation in systemic sclerosis
Jacob M van Laar, Keith Sullivan
Best Practice & Research. Clinical Rheumatology
|
December 8, 2014
Concepts of pathogenesis and emerging treatments for inflammatory arthritis
Jacob M van Laar, Arthur Kavanaugh
Best Practice & Research. Clinical Rheumatology
|
August 25, 2010
Stem cells in the treatment of inflammatory arthritis
Alan Tyndall, Jacob M van Laar
Current Rheumatology Reports
|
July 22, 2008
Cellular therapy of systemic sclerosis
Jacob M van Laar, Alan Tyndall
Arthritis Research & Therapy
|
October 25, 2008
Stem cell transplantation for rheumatic autoimmune diseases
Thomas Hügle, Jacob M van Laar
Page
of 23
Search research articles
Search
Showing results (1-10 of 230) with videos related to
Sort By:
Page
of 23
Rheumatology (Oxford, England)
|
December 29, 2016
Rheumatology post-Brexit
Jacob M van Laar
Therapeutic Advances in Musculoskeletal Disease
|
August 8, 2012
Stem cell therapy: resetting autoimmunity or postponing the inevitable?
Jacob M van Laar
Nature Clinical Practice. Rheumatology
|
August 30, 2007
Do high levels of IgA rheumatoid factor indicate a poor response to treatment with TNF inhibitors in patients with RA?
Jacob M van Laar
Nature Clinical Practice. Rheumatology
|
November 30, 2006
Antibodies against citrullinated proteins: which test is best?
Jacob M van Laar
Arthritis Research & Therapy
|
May 6, 2010
B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
Jacob M van Laar
Current Opinion in Rheumatology
|
September 20, 2013
Stem cell transplantation in systemic sclerosis
Jacob M van Laar, Keith Sullivan
Best Practice & Research. Clinical Rheumatology
|
December 8, 2014
Concepts of pathogenesis and emerging treatments for inflammatory arthritis
Jacob M van Laar, Arthur Kavanaugh
Best Practice & Research. Clinical Rheumatology
|
August 25, 2010
Stem cells in the treatment of inflammatory arthritis
Alan Tyndall, Jacob M van Laar
Current Rheumatology Reports
|
July 22, 2008
Cellular therapy of systemic sclerosis
Jacob M van Laar, Alan Tyndall
Arthritis Research & Therapy
|
October 25, 2008
Stem cell transplantation for rheumatic autoimmune diseases
Thomas Hügle, Jacob M van Laar
Page
of 23